Tag: Seema Ahuja

Biocon Wins MYR 300 Million Contract for Insulin from MoH, Malaysia

IDF 2015   #www.diabetes.org.my   ^ 1MYR= INR15.37 as on Jan24, 2017   About Biocon Ltd Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is India’s largest and fully-integrated, innovation-led biopharmaceutical company. As an emerging global biopharmaceutical enterprise serving customers in over 120 countries, it

Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India

WHO # Source: Lancet   About Biocon   Biocon Limited, publicly listed in 2004, (BSE code: 532523, NSE Id: BIOCON, ISIN Id: INE376G01013) is India's largest and fully-integrated, innovation-led biopharmaceutical company. As an emerging global biopharmaceutical enterprise serving customers in over 120 countries, it is committed to reduce therapy costs

Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency

  Source : Biocon Limited Thursday, July 21, 2016 7:54PM IST (2:24PM GMT)   (BSE:532523)(NSE:BIOCON) Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency   HERTFORDSHIRE, England, Bengaluru, Karnataka, India and Pittsburgh, United States Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd.